Reducing Risks in Type 1 Diabetes Using ${\cal H}_\infty$ Control

A control scheme was designed in order to reduce the risks of hyperglycemia and hypoglycemia in type 1 diabetes mellitus (T1DM). This structure is composed of three main components: an H∞ robust controller, an insulin feedback loop (IFL), and a safety mechanism (SM). A control-relevant model that is employed to design the robust controller is identified. The identification procedure is based on the distribution version of the UVA/Padova metabolic simulator using the simulation adult cohort. The SM prevents dangerous scenarios by acting upon a prediction of future glucose levels, and the IFL modifies the loop gain in order to reduce postprandial hypoglycemia risks. The procedure is tested on the complete in silico adult cohort of the UVA/Padova metabolic simulator, which has been accepted by the Food and Drug Administration (FDA) in lieu of animal trials.

[1]  Ricardo Femat,et al.  Blood glucose control for type I diabetes mellitus: A robust tracking H∞ problem , 2004 .

[2]  K. Turksoy,et al.  Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. , 2013, Diabetes technology & therapeutics.

[3]  A. S. Ghersin,et al.  Time-Varying Procedures for Insulin-Dependent Diabetes Mellitus Control , 2011, J. Electr. Comput. Eng..

[4]  J. Bondia,et al.  El Páncreas Artificial, Control Automático de Infusión de Insulina en Diabetes Mellitus Tipo 1 , 2010 .

[5]  Fernando Daniel Bianchi,et al.  Model selection: From LTI to switched-LPV , 2012, 2012 American Control Conference (ACC).

[6]  C. Cobelli,et al.  Artificial Pancreas: Past, Present, Future , 2011, Diabetes.

[7]  E. Atlas,et al.  MD-Logic Artificial Pancreas System: A Pilot Study in Adults with Type 1 Diabetes Mellitus Running Title: Closed-Loop System In Type 1 Diabetes , 2010 .

[8]  L. Magni,et al.  Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results , 2010, Journal of diabetes science and technology.

[9]  Eyal Dassau,et al.  Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring , 2010, Diabetes Care.

[10]  Claudio Cobelli,et al.  GIM, Simulation Software of Meal Glucose—Insulin Model , 2007, Journal of diabetes science and technology.

[11]  B. Wayne Bequette,et al.  Challenges and progress in the development of a closed-loop artificial pancreas , 2012, 2012 American Control Conference (ACC).

[12]  F. El-Khatib,et al.  Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas , 2012, Diabetes Care.

[13]  Roman Hovorka,et al.  Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes , 2010, Journal of diabetes science and technology.

[14]  Lauren M. Huyett,et al.  Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms , 2014, Diabetes Care.

[15]  C S Hughes,et al.  Anticipating the next meal using meal behavioral profiles: A hybrid model-based stochastic predictive control algorithm for T1DM , 2011, Comput. Methods Programs Biomed..

[16]  Christofer Toumazou,et al.  A Bio-Inspired Glucose Controller Based on Pancreatic β-Cell Physiology , 2012, Journal of diabetes science and technology.

[17]  Anirban Roy,et al.  The effect of insulin feedback on closed loop glucose control. , 2011, The Journal of clinical endocrinology and metabolism.

[18]  Eyal Dassau,et al.  In Silico Preclinical Trials: Methodology and Engineering Guide to Closed-Loop Control in Type 1 Diabetes Mellitus , 2009, Journal of diabetes science and technology.

[19]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[20]  Patricio Colmegna,et al.  Analysis of three T1DM simulation models for evaluating robust closed-loop controllers , 2014, Comput. Methods Programs Biomed..

[21]  Eyal Dassau,et al.  Zone Model Predictive Control: A Strategy to Minimize Hyper- and Hypoglycemic Events , 2010, Journal of diabetes science and technology.

[22]  Bruce Zimmerman,et al.  Medical Management of Type 2 Diabetes , 2003 .

[23]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[24]  Francis J. Doyle,et al.  Robust H∞ glucose control in diabetes using a physiological model , 2000 .

[25]  Eyal Dassau,et al.  Control to Range for Diabetes: Functionality and Modular Architecture , 2009, Journal of diabetes science and technology.

[26]  E. Dassau,et al.  Closing the loop , 2012, International journal of clinical practice. Supplement.

[27]  Darrell M. Wilson,et al.  A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator , 2009, Journal of diabetes science and technology.

[28]  R. Hovorka,et al.  Simulation models for in silico testing of closed-loop glucose controllers in type 1 diabetes , 2008 .

[29]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[30]  L. Magni,et al.  Diabetes: Models, Signals, and Control , 2010, IEEE Reviews in Biomedical Engineering.

[31]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[32]  Rolf Johansson,et al.  Subspace-Based Model Identification of Diabetic Blood Glucose Dynamics , 2009 .

[33]  E. Atlas,et al.  MD-Logic Artificial Pancreas System , 2010, Diabetes Care.

[34]  Dale E. Seborg,et al.  Control-Relevant Models for Glucose Control Using A Priori Patient Characteristics , 2012, IEEE Transactions on Biomedical Engineering.

[35]  F. Wolf.  Standards of Medical Care in Diabetes—2014 , 2013, Diabetes Care.

[36]  Konstantina S. Nikita,et al.  An Insulin Infusion Advisory System Based on Autotuning Nonlinear Model-Predictive Control , 2011, IEEE Transactions on Biomedical Engineering.

[37]  John Thomas Sorensen,et al.  A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes , 1985 .

[38]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[39]  Bart De Moor,et al.  N4SID: Subspace algorithms for the identification of combined deterministic-stochastic systems , 1994, Autom..

[40]  Moshe Phillip,et al.  Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project. , 2012, Diabetes technology & therapeutics.

[41]  Eyal Dassau,et al.  Safety Constraints in an Artificial Pancreatic β Cell: An Implementation of Model Predictive Control with Insulin on Board , 2009, Journal of diabetes science and technology.

[42]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.

[43]  F. El-Khatib,et al.  A Feasibility Study of Bihormonal Closed-Loop Blood Glucose Control Using Dual Subcutaneous Infusion of Insulin and Glucagon in Ambulatory Diabetic Swine , 2009, Journal of diabetes science and technology.